-+ 0.00%
-+ 0.00%
-+ 0.00%

NextCure Q2 EPS $(2.80) Misses $(1.94) Estimate

Benzinga·08/06/2026 21:47:28
Listen to the news
NextCure (NASDAQ:NXTC) reported quarterly losses of $(2.80) per share which missed the analyst consensus estimate of $(1.94) by 45.08 percent. This is a 75.2 percent increase over losses of $(11.29) per share from the same period last year.